AD7C Test

AD7C Test

A biochemical test which measures a 41-kD neural thread protein in cerebrospinal fluid or urine and which is said to be useful in diagnosing Alzheimer's disease. The reports on the efficacy of this test are in second-tier journals and dated (1998 and 2002).
References in periodicals archive ?
Editor's note: To order the AD7C test for Alzheimer's disease, physicians can call Nymox Pharmaceutical Corporation at 1-800-936-9669.
The AD7C test, produced by Nymox Pharmaceutical Corporation, measures the level of a protein produced in the brain.
The AD7C test measures a substance produced in the brain called neural thread protein.
Nymox welcomes the additional positive attention and recognition of the AD7C test resulting from publication of these two books," said Dr.
Q: Could you tell us about your company's AD7C test to help physicians detect Alzheimer's disease?
1999 ) referred to Nymox's AD7C test as "a successful in vitro diagnostic".
The number of AD7C shipping containers sent out for the reference laboratory clinical AD7C test was 1,666 in the last nine months.
The AD7C test is the company's current version of the neuronal thread protein test, which requires sending a urine specimen to Nymox's clinical reference laboratory in Kensington, Md.
The new `7C Gold' test will take only several minutes to perform, and is a generational leap ahead compared to our current AD7C test which requires overnight incubation and two days to perform," said Michael Munzar, M.
VA Medical center and a leader in AD treatment, as saying that "In several cases, the AD7C test has been very helpful" in accomplishing the mission of the hospital's AD clinic.
Nymox currently markets the AD7C test as an aid to physicians in the diagnosis and management of Alzheimer's Disease ("AD") and to help rule out the diagnosis of AD in cases that are not AD.
18, 1998--Nymox Pharmaceutical Corporation (NASDAQ National Market: NYMXF; Montreal Exchange: NMX) today announced that clinical testing with the AD7C test has been shown to be useful to aid in the diagnosis of dementia associated with Down syndrome.